Ifebemtinib，BI 853520

Non chimik:

4-[[4-[(2,3-Dihydro-2-methyl-3-oxo-1H-izoindol-4-yl)oxy]-5-(trifluorometil)-2-pirimidinyl]amino]-2-fluoro- 5-metoksi-N-(1-methyl-4-piperidinyl)benzamid

Kòd SMILES:

O=C(NC1CCN(C)CC1)C2=CC(OC)=C(NC3=NC=C(C(F)(F)F)C(OC4=CC=CC(CN5C)=C4C5=O)= N3)C=C2F

Kòd InChi:

InChI=1S/C28H28F4N6O4/c1-37-9-7-16(8-10-37)34-24(39)17-11-22(41-3)20(12-19(17)29)35- 27-33-13-18(28(30,31)32)25(36-27)42-21-6-4-5-15-14-38(2)26(40)23(15)21/ h4-6,11-13,16H,7-10,14H2,1-3H3,(H,34,39)(H,33,35,36)

InChi kle:

ULMMVBPTWVRPSI-UHFFFAOYSA-N

Mot:

1227948-82-4；CAS:1227948-82-4；CAS:1227948-82-4；Ifebemtinib；BI 853520

Solibilite:Soluble nan DMSO, pa nan dlo

Depo:0 - 4 C pou kout tèm (jou a semèn), oswa -20 C pou long tèm (mwa).

Deskripsyon:

Ifebemtinib (BI 853520) se yon inibitè ki pisan nan fokal Adhesion kinase (FAK) ak aktivite oral.

Sib: FAK Strong Inhibitor